Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Cash: 2024-2025

Historic Change in Cash for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$1.8 million.

  • Pyxis Oncology's Change in Cash rose 86.07% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 105.78% up from last year.
  • Pyxis Oncology's Change in Cash amounted to -$1.8 million in Q3 2025, which was up 10.46% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Change in Cash peaked at $18.3 million during Q1 2024, and registered a low of -$13.0 million during Q3 2024.
  • Moreover, its 2-year median value for Change in Cash was -$2.0 million (2025), whereas its average is -$106,429.
  • Within the past 5 years, the most significant YoY rise in Pyxis Oncology's Change in Cash was 86.07% (2025), while the steepest drop was 136.68% (2025).
  • Over the past 2 years, Pyxis Oncology's Change in Cash (Quarterly) stood at $7.4 million in 2024, then surged by 86.07% to -$1.8 million in 2025.
  • Its Change in Cash was -$1.8 million in Q3 2025, compared to -$2.0 million in Q2 2025 and -$6.7 million in Q1 2025.